These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 30407498

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
    Mtshali A, San JE, Osman F, Garrett N, Balle C, Giandhari J, Onywera H, Mngomezulu K, Mzobe G, de Oliveira T, Rompalo A, Mindel A, Abdool Karim SS, Ravel J, Passmore JS, Abdool Karim Q, Jaspan HB, Liebenberg LJP, Ngcapu S.
    Front Immunol; 2021; 12():730986. PubMed ID: 34594336
    [Abstract] [Full Text] [Related]

  • 3. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
    Dabee S, Barnabas SL, Lennard KS, Jaumdally SZ, Gamieldien H, Balle C, Happel AU, Murugan BD, Williamson AL, Mkhize N, Dietrich J, Lewis DA, Chiodi F, Hope TJ, Shattock R, Gray G, Bekker LG, Jaspan HB, Passmore JS.
    PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
    [Abstract] [Full Text] [Related]

  • 4. Vaginal fungi are associated with treatment-induced shifts in the vaginal microbiota and with a distinct genital immune profile.
    Armstrong E, Hemmerling A, Miller S, Huibner S, Kulikova M, Liu R, Crawford E, Castañeda GR, Coburn B, Cohen CR, Kaul R.
    Microbiol Spectr; 2024 Aug 06; 12(8):e0350123. PubMed ID: 38912808
    [Abstract] [Full Text] [Related]

  • 5. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
    Reimers LL, Mehta SD, Massad LS, Burk RD, Xie X, Ravel J, Cohen MH, Palefsky JM, Weber KM, Xue X, Anastos K, Minkoff H, Atrio J, D'Souza G, Ye Q, Colie C, Zolnik CP, Spear GT, Strickler HD.
    J Infect Dis; 2016 Nov 01; 214(9):1361-1369. PubMed ID: 27521363
    [Abstract] [Full Text] [Related]

  • 6. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
    Kyongo JK, Crucitti T, Menten J, Hardy L, Cools P, Michiels J, Delany-Moretlwe S, Mwaura M, Ndayisaba G, Joseph S, Fichorova R, van de Wijgert J, Vanham G, Ariën KK, Jespers V.
    Clin Vaccine Immunol; 2015 May 01; 22(5):526-38. PubMed ID: 25761460
    [Abstract] [Full Text] [Related]

  • 7. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C, Deng ZL, Vital M, Masur C, Abels C, Pieper DH, Rohde M, Mendling W, Wagner-Döbler I.
    Microbiome; 2017 Sep 13; 5(1):119. PubMed ID: 28903767
    [Abstract] [Full Text] [Related]

  • 8. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility.
    Mohammadi A, Bagherichimeh S, Perry MC, Fazel A, Tevlin E, Huibner S, Tharao W, Coburn B, Kaul R.
    Sci Rep; 2020 May 22; 10(1):8514. PubMed ID: 32444843
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology.
    Shannon B, Gajer P, Yi TJ, Ma B, Humphrys MS, Thomas-Pavanel J, Chieza L, Janakiram P, Saunders M, Tharao W, Huibner S, Shahabi K, Ravel J, Kaul R.
    J Infect Dis; 2017 May 01; 215(9):1366-1375. PubMed ID: 28201724
    [Abstract] [Full Text] [Related]

  • 11. Single-Molecule Approach to 16S rRNA for Vaginal Microbiome Signatures in Response to Metronidazole Treatment.
    Qin H, Jiao J, A D, Hua M, Han K, Du H, Wang Z, Li J, Zhang D, Xiao B, Chen C.
    Microbiol Spectr; 2023 Jun 15; 11(3):e0170622. PubMed ID: 37199621
    [Abstract] [Full Text] [Related]

  • 12. Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women.
    Garrett N, Mtshali A, Osman F, Masson L, McKinnon LR, Singh R, Mitchev N, Ngobese H, Kharsany ABM, Abdool Karim S, Mlisana K, Passmore JA, Rompalo A, Mindel A, Liebenberg L.
    Sex Transm Infect; 2021 Dec 15; 97(8):555-565. PubMed ID: 33608480
    [Abstract] [Full Text] [Related]

  • 13. Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment.
    Rebbapragada A, Howe K, Wachihi C, Pettengell C, Sunderji S, Huibner S, Ball TB, Plummer FA, Jaoko W, Kaul R.
    J Acquir Immune Defic Syndr; 2008 Dec 15; 49(5):520-2. PubMed ID: 18989228
    [Abstract] [Full Text] [Related]

  • 14. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.
    Verwijs MC, Agaba SK, Darby AC, van de Wijgert JHHM.
    Am J Obstet Gynecol; 2020 Feb 15; 222(2):157.e1-157.e13. PubMed ID: 31404542
    [Abstract] [Full Text] [Related]

  • 15. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study.
    Masson L, Barnabas S, Deese J, Lennard K, Dabee S, Gamieldien H, Jaumdally SZ, Williamson AL, Little F, Van Damme L, Ahmed K, Crucitti T, Abdellati S, Bekker LG, Gray G, Dietrich J, Jaspan H, Passmore JS.
    Sex Transm Infect; 2019 Feb 15; 95(1):5-12. PubMed ID: 30018088
    [Abstract] [Full Text] [Related]

  • 16. Deep sequencing of the vaginal microbiota of women with HIV.
    Hummelen R, Fernandes AD, Macklaim JM, Dickson RJ, Changalucha J, Gloor GB, Reid G.
    PLoS One; 2010 Aug 12; 5(8):e12078. PubMed ID: 20711427
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differences in Vaginal Microbiota, Host Transcriptome, and Proteins in Women With Bacterial Vaginosis Are Associated With Metronidazole Treatment Response.
    Serebrenik J, Wang T, Hunte R, Srinivasan S, McWalters J, Tharp GK, Bosinger SE, Fiedler TL, Atrio JM, Murphy K, Barnett R, Ray LR, Krows ML, Fredricks DN, Irungu E, Ngure K, Mugo N, Marrazzo J, Keller MJ, Herold BC.
    J Infect Dis; 2021 Dec 15; 224(12):2094-2104. PubMed ID: 34003290
    [Abstract] [Full Text] [Related]

  • 19. Association of Chlamydia trachomatis burden with the vaginal microbiota, bacterial vaginosis, and metronidazole treatment.
    Ardizzone CM, Taylor CM, Toh E, Lillis RA, Elnaggar JH, Lammons JW, Mott PD, Duffy EL, Shen L, Quayle AJ.
    Front Cell Infect Microbiol; 2023 Dec 15; 13():1289449. PubMed ID: 38149008
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.